Skip to main content
Clinical Trials/CTRI/2018/05/014141
CTRI/2018/05/014141
Completed
Phase 2

Clinical Evaluation of Efficacy of ââ?¬Å?Rasnadi Gugguluââ?¬? , ââ?¬Å?Rasnadashamooladi Kwathaââ?¬? and ââ?¬Å?Griva Vastiââ?¬? in the Management of Griva-Sandhigata Vata (Cervical Spondylosis)

ational Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Cervical Spondylosis
Sponsor
ational Institute of Ayurveda
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients willing to signature the consent form for the clinical trial.
  • 2\.Patients of either sex.
  • 3\. Patients above 20 years and less than 70 years.
  • 4\. Clinical symptoms of ââ?¬Ë?Griva\-Sandhigata Vataââ?¬• (Cervical Spondylosis) with or without radiological changes.

Exclusion Criteria

  • 1\.Stenosis of spinal cord
  • 2\.Contraindication and allergy to any drug in Rasnadi Guggulu, Rasnadashamooladi Kwatha or Dashamooladi Taila used for Griva Vasti.
  • 3\.Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy.
  • 4\.Myofacial pain
  • 5\.Patients suffering from any infectious disease (like tuberculosis), metabolic disease (like diabetes mellitus and hypothyroidism), chronicdisease (like rheumatoid arthritis, SLE, ankylosing spondylitis).
  • 6\.Pregnant and lactating mothers.

Outcomes

Primary Outcomes

Not specified

Similar Trials